|
MFSD8 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.073800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.734420E-01 |
| Normal-vs-Stage2 |
5.595000E-01 |
| Normal-vs-Stage3 |
1.526560E-01 |
| Normal-vs-Stage4 |
3.431600E-01 |
| Stage1-vs-Stage2 |
1.416370E-01 |
| Stage1-vs-Stage3 |
5.841800E-01 |
| Stage1-vs-Stage4 |
6.770800E-01 |
| Stage2-vs-Stage3 |
1.428830E-01 |
| Stage2-vs-Stage4 |
2.845800E-01 |
| Stage3-vs-Stage4 |
9.530000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.642630E-01 |
| Normal-vs-AfricanAmerican |
7.193800E-01 |
| Normal-vs-Asian |
1.391010E-01 |
| Caucasian-vs-AfricanAmerican |
5.411800E-01 |
| Caucasian-vs-Asian |
5.818200E-01 |
| AfricanAmerican-vs-Asian |
5.281600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.860780E-01 |
| Normal-vs-Female |
4.795600E-01 |
| Male-vs-Female |
7.279600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.426200E-01 |
| Normal-vs-Extreme_Weight |
8.828300E-02 |
| Normal-vs-Obese |
5.402000E-01 |
| Normal-vs-Extreme_Obese |
3.846400E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.593600E-01 |
| Normal_Weight-vs-Obese |
7.124400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.630600E-01 |
| Extreme_Weight-vs-Obese |
3.544800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.326200E-01 |
| Obese-vs-Extreme_Obese |
7.863200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.502400E-01 |
| Normal-vs-Age(41-60Yrs) |
9.966000E-01 |
| Normal-vs-Age(61-80Yrs) |
6.511600E-02 |
| Normal-vs-Age(81-100Yrs) |
2.073200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.527000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.467600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.881000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.056000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.038000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.775400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.937000E-01 |
| Normal-VS-Type2 PRCC |
1.773860E-02 |
| Normal-VS-KIRP CIMP |
2.895800E-03 |
| Normal-VS-Unclassified PRCC |
4.980600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.537930E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.030200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.584200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.991600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.260600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.232500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.186300E-02 |
| Normal-vs-N1 |
3.724800E-01 |
| Normal-vs-N2 |
6.163400E-04 |
| N0-vs-N1 |
5.828000E-01 |
| N0-vs-N2 |
4.591800E-02 |
| N1-vs-N2 |
1.199980E-01 |
|
|
